(Q40220752)
Statements
Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (English)
Jose Luis Martín-Ventura
Eduardo de Teresa
Csaba Farsang
Allan Gaw
GianFranco Gensini
Lawrence A Leiter
Anatoly Langer
Pierre Martineau
Jesús Egido
ACTFAST investigators